The 57 references in paper Ye. Grigoryev V., Ye. Kameneva A., T. Grishanova G., M. Deragin N., A. Budayev V., Е. Григорьев В., Е. Каменева А., Т. Гришанова Г., А. Будаев В., О. Дербенева А. (2010) “Маркеры повреждения головного мозга при тяжелой сочетанной травме // Markers of Brain Damage in Severe Concomitant Injury” / spz:neicon:reanimatology:471

1
Сингаевский А. Б., Карнасевич Ю. А., Малых И. Ю.Причины летальных исходов при тяжелой сочетанной травме. Вестн. хирургии им. И. И. Грекова 2002; 2: 62—65.
(check this in PDF content)
2
Шах Б. Н.Диагностика и коррекция нарушений гомеостаза у пострадавших с механическими шокогенными повреждениями в остром периоде травматической болезни: автореф. дис. ... д-ра мед. наук. СПб.; 2006: 42.
(check this in PDF content)
3
Багненко С. Ф., Шах Б. Н., Теплов В. М.Возможности коррекции гипоксических и реперфузионных повреждений у пострадавших с сочетанной шокогенной травмой в остром периоде травматической болезни. В кн.: Тезисы докладов Всероссийской конференции «Реаниматология — наука о критических состояниях». М.; 2006. 11—12.
(check this in PDF content)
4
Ганнушкина И. В.Иммунологические аспекты травмы и сосудистых поражений мозга. М.: Медицина; 1994.
(check this in PDF content)
5
Gentleman S. M., Leclercq P. D., Moyes L. et al. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic. Sci. Int. 2004; 146 (2—3): 97—104.
(check this in PDF content)
6
Wang X., Feuerstein G. Z. Role of immune and inflammatory mediators in CNS injury. Drug News Perspect. 2000; 13 (3): 133—140.
(check this in PDF content)
7
Andrews P. J., Piper I. R., Dearden N. M., Miller J. D. Secondary insults during intrahospital transport of head injured patients. Lancet 1990; 335 (8685): 327—330.
(check this in PDF content)
8
Dorsch N. W., Zurynski Y. A.Post-traumatic vasospasm influences head injury outcome. Can. J. Neurol. Sci. 1993; 10: 28.
(check this in PDF content)
9
Шанин В. Ю. Патофизиология критических состояний. СПб.: ЭЛБИ-СПб.; 2003. 436.
(check this in PDF content)
10
Будаев А. В.Тканевой кровоток головного мозга в постреанимационном периоде у животных, перенесших клиническую смерть. Общая реаниматология 2006; II (5—6): 79—84.
(check this in PDF content)
11
Заржецкий Ю. В., Аврущенко М. Ш., Волков А. В.Нейрофизиологические механизмы постреанимационного повреждения мозга. Общая реаниматология 2006; II (5—6): 101—110.
(check this in PDF content)
12
Острова И. В., Мороз В. В., Аврущенко М. Ш. Значение иммуногистохимических исследований белков теплового шока семейства HSP 70 для изучения постреанимационных изменений мозга. Общая реаниматология 2007; III (5—6): 91—96.
(check this in PDF content)
13
Aguilar L. C, Islas A., Rosique P. et al. Psychometric analysis in children with mental retardation due to perinatal hypoxia treated with fibroblast growth factor (FGF) & showing improvement in mental development. J. Intellect Disabil. Res. 1993; 37 (Pt 6): 507—520.
(check this in PDF content)
14
Kubo T. Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture. Brain Res. Dev. Brain Res. 1995; 85 (2): 249—258.
(check this in PDF content)
15
Петрищев Н. Н., Беркович О. А., Власов Т. Д. и соавт.Диагностическая ценность циркулирующих эндотелиальных клеток в крови. Клинич. лаб. диагностика 2001; 1: 50—52. www.niiorramn.ru
(check this in PDF content)
16
Dimmeler S., Hermann C., Zeiher A. M. Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur. Cytokine Netw. 1998; 9 (4): 697—698.
(check this in PDF content)
17
Жданов Г. Н., Герасимова М. М. Оценка роли аутоиммунной воспалительной реакции в патогенезе церебральной ишемии. Невролог. вестн. 2003; 35 (3—4): 13—17.
(check this in PDF content)
18
Скворцова В. И., Шерстнёв В. В., Константинова Н. А. и соавт. Участие аутоиммунных механизмов в развитии ишемического повреждения головного мозга. Журн. неврологии и психиатрии им. С. С. Корсакова 2005; 105 (8): 36—40.
(check this in PDF content)
19
Чехонин В. П., Гурина О. И., Рябухин И. А. и соавт.Иммуноферментный анализ нейронспецифической енолазы на основе моноклональных антител в оценке проницаемости гематоэнцефалического барьера при нервно-психических заболеваниях. Росс. психиатр. журн. 2000; 4: 15—19.
(check this in PDF content)
20
Lamers K. J., van Engelen B. G., Gabreels F. J. et al. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol. Scand. 1995; 92 (3): 247—251.
(check this in PDF content)
21
Missler U., Wiesmann M., Friedrich C., Kaps M.S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28 (10): 1956—1960.
(check this in PDF content)
22
Шумахер Г. И., Воробьёва Е. Н., Нечунаева Е. В. и соавт. Роль дисфункции эндотелия в запуске иммунопатологических реакций при хронической ишемии головного мозга. Бюл. Сибирской медицины 2008; 5: 214—219.
(check this in PDF content)
23
Крижановский Г. Н.Общая патофизиология нервной системы. М.; 1997. 349.
(check this in PDF content)
24
Гурина О. И.Клинико-иммунохимическая оценка нарушений функций гемато-энцефалического барьера у недоношенных детей с перинатальными поражениями ЦНС: автореф. дис. ... канд. мед. наук. М.; 1996.
(check this in PDF content)
25
Moore B. W.A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 1965; 19 (6): 739—744.
(check this in PDF content)
26
Zimmer D.B., Cornwall E.H., Landar A., Song W.The S100 protein family: history, function, and expression. Brain Res. Bull. 1995; 37 (4): 417—429.
(check this in PDF content)
27
Donato R. S-100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001; 33 (7): 637—668.
(check this in PDF content)
28
Heizmann C. W.Ca2+-binding S100 proteins in the central nervous system. Neurochem. Res. 1999; 24 (9): 1097—1100.
(check this in PDF content)
29
Petzold A., Green A. J., Keir G. et al.Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study. Crit. Care Med. 2002; 30 (12): 2705—2710.
(check this in PDF content)
30
Raabe A., Grolms C., Sorge O. et al.Serum of S-100 protein in severe head injury. Neurosurgery 1999; 45 (3): 477—483.
(check this in PDF content)
31
Raabe A., Grolms C., Seifert V. Serum markers of brain damage and outcome prediction after severe head injury. Br. J. Neurosurg. 1999; 13 (1): 56—59.
(check this in PDF content)
32
Ingebrigtsen T., Waterloo K., Jacobsen E. A. et al.Traumatic brain damage in minor head injury: relation of serum S100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45 (3): 468—476.
(check this in PDF content)
33
Mussack T., Biberthaler P., Kanz K. G. et al.Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit. Care Med. 2002; 30 (12): 2669—2674.
(check this in PDF content)
34
Bottiger B. W., Mobes S., Glatzer R. et al.Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103 (22): 2694—2698.
(check this in PDF content)
35
Mussack T., Biberthaler P., Kanz K. G. et al.Immediate S100B and neuron-specific enolase plasma measurements or rapid evaluation of primary brain damage in alcoholintoxicated, minor head-injured patients. Shock 2002; 18 (5): 395—400.
(check this in PDF content)
36
Ali M. S., Harmer M., Vaughan R.Serum protein S100 as a marker of cerebral damage during cardiac surgery. Br. J. Anaesth. 2000; 85 (2): 287—298.
(check this in PDF content)
37
Wiesmann M., Missler U., Hagenstrom H., Gottmann D.S-100 protein plasma levels after aneurismal subarachnoid haemorrhage. Acta Neurochir. (Wien) 1997; 139 (12): 1155—1160.
(check this in PDF content)
38
Pelinka L. E., Bahrami S., Szalay L. et al.Hemorrhagic shock induces an S100B increase associated with shock severity. Shock 2003; 19 (5): 422—426.
(check this in PDF content)
39
Pelinka L. E., Szalay L., Jafarmadar M. et al. Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br. J. Anaesth. 2003; 91 (4): 595—597.
(check this in PDF content)
40
Pelinka L. E., Toegel E., Mauritz W., Redl H.Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003; 19 (3): 195—200.
(check this in PDF content)
41
Biberthaler P., Linsenmeier U., Pfeifer K. J. et al. Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury: A prospective multicenter study. Shock 2006; 25 (5): 446—453.
(check this in PDF content)
42
Hayakata T., Shiozaki T., Tasaki O. et al.Changes in CSF S100b and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004; 22 (2): 102—107.
(check this in PDF content)
43
Marangos P. J., Schmechel D. E. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu. Rev. Neurosci. 1987; 10: 269—295.
(check this in PDF content)
44
Woertgen C., Rothoerl R. D., Holzschuh M. et al.Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir. (Wien) 1997; 139 (12): 1161—1165.
(check this in PDF content)
45
Martens P., Raabe A., Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29 (11): 2363—2366.
(check this in PDF content)
46
Georgiadis D., Berger A., Kowatchev E. et al.Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J. Thorac. Cardiovasc. Surg. 2000; 119 (1): 138—147.
(check this in PDF content)
47
Wunderlich M. T., Ebert A. D., Kratz T. et al. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30 (6): 1190—1195.
(check this in PDF content)
48
Rosen H., Sunnerhagen K. S., Herlitz J. et al.Serum levels of the brainderived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001; 49 (2): 183—191.
(check this in PDF content)
49
Weigand M. A., Volkmann M., Schmidt H. et al.Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis and septic shock. Anesthesiology 2000; 92 (3): 905—907.
(check this in PDF content)
50
Moreno R., Vincent J. L., Matos R. et al.The use of the maximum SOFA score to quantify organ dysfunction/failure in intensive care: Results of a prospective, multicenter study. Intensive Care Med. 1999; 25 (7): 686—696.
(check this in PDF content)
51
Bleck T. P., Smith M. C., Pierre;Louis S. J. et al.Neurologic complications of critical medical illness. Crit. Care Med. 1993; 21 (1): 98—103.
(check this in PDF content)
52
Eidelman L. A., Putterman D., Putterman C., Sprung C. L.The spectrum of septic encephalopathy: Definitions, etiologies and mortalities. JAMA 1996; 275 (6): 470—473.
(check this in PDF content)
53
Gogos C. A., Lekkou A., Papageorgiou O. et al. Clinical prognostic markers in patients with severe sepsis: A prospective analysis of 139 consecutive patients. J. Infect. 2003; 47 (4): 300—306.
(check this in PDF content)
54
Young G. B.Septic encephalopathy. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J. L. (Ed.). New York: Springer; 2002: 748—753.
(check this in PDF content)
55
Marshall J. C., Cook D. J., Christou N. V. et al.Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 1995; 23 (10): 1638—1652.
(check this in PDF content)
56
Nguyen D. N., Spapen H., Su F. et al.Elevated serum levels of S-100β protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med. 2006; 34 (7): 1967—1974.
(check this in PDF content)
57
Routsi C., Stamataki E., Nanas S. et al.Increased levels of serum s100b protein in critically ill patients without brain injury. Shock 2006; 26 (1): 20—24. Поступила 14.01.10
(check this in PDF content)